Originally posted by Malaga
EX1 I missed the start as watching cricket. Thought I will wait for pull back on profit takers. Strength right thru to close. Will pick up some when excitement dies down. Bio and Tech for me in 2019. Will not touch,
Coal, Uranium or cash strapped explorers. Will trade a few hotcopper pumps but they just don't make pumpers the way they used to. I still think CYP can take off sometime in next 3 months but those Japs are very slow to do business with.
Got a few xmas functions lined up and been told not to talk, politics , shares or money so looks like I got nufin to say.
haaha, "
Will trade a few hotcopper pumps but they just don't make pumpers the way they used to.
"
They will come again, always do, and there's always a few if you are lucky, but not easy as an ol Port Phillips pump eh.
It's good punters are getting wiser, and as they should do after so much sham the last few years. It's easier to reinvest fast profits into specs when even rubbish is firing...and that has dried up. Good thing imo. Obvious stuff now to most. (shells/ tech etc)
CYP has had it's long consol last 6 months from 1.58 highs, but I still think it does have all the makings 2019 (even I have sold a few to make room)
3x phase 2 trials 2019 given many bios are valued $50-100m on just 1 Phase 2, It has a better risk reward than EX1 2019 from here, agree.
but logic seems to go out the window ST on many ASX juniors. CYP also now has a 90 days countdown to their first big commercial deal with FujiFilm after todays ann. they might go early 2019....
Going back a few years now, we had 3 "Unicorns" entered into STT. SYT, IAM and CYP. I am still glad to be on the right horse, but yet to grow the horn.
SYT and IAM have gone back at least 80% since then.
Always learning.
be a good weekend thread to get the STT team view on potential unicorns 2019.
Given Dixon's track record, CYP, NOX, EX1,
I'd take a look at MGZ plans next few years and try get some capital raise ops there. ($3m cap). have a very commercial and well know opportunity in back disc degeneration therapy.